Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Recent RECOVER research has revealed important links between Long COVID and a range of other physical, mental, and emotional health conditions.
During 2 webinars hosted to raise awareness about pediatric Long COVID, RECOVER researchers and a RECOVER Representative discussed recent study findings, including how Long COVID affects the developing brain.
RECOVER Representatives use their lived experience and feedback from their communities to make recommendations that help make RECOVER-SLEEP trial participation simpler and more accessible.
The RECOVER Digital Health Program used wearable devices to monitor participants’ health data and understand how Long COVID affected their daily activities and sleep.
NIH leaders and RECOVER researchers will provide updates on RECOVER-Treating Long COVID (RECOVER-TLC), the next phase of RECOVER Long COVID clinical trials.
Leveraging staff expertise and consistent monitoring, a RECOVER-ENERGIZE clinical trial is exploring whether a personalized cardiopulmonary rehabilitation program can help people with Long COVID regain physical activity.
RECOVER released a call for ancillary pathobiology study proposals that will build on the more than 60 existing funded studies and will address unanswered questions about Long COVID.
Researchers found that severe COVID-19 can cause a strong immune response, which can cause the body’s immune system to attack itself and lead to new autoimmune diseases.
Drawing on her experience working in intensive care, expertise in lung health, and knowledge of medical imaging, Dr. Brosnahan is leading studies that could inform the development of treatments for specific Long COVID symptoms.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.